By:-
Archan Diviti
• A paraneoplastic syndrome is
a disease or symptom that is the
consequence of cancer in the body but,
not due to the local presence of cancer
cells.
• These phenomena are mediated
by humoral factors (by hormones
or cytokines) excreted by tumor cells or by
an immune response against the tumor.
• They appear in 10% to 15% of
patients with cancer.
• Paraneoplastic syndromes are typical
among middle aged to older patients,
and they most commonly present with
cancers of the lung, breast, ovaries or
lymphatic system (a lymphoma).
• Paraneoplastic syndromes
can be divided into four
main categories:
1.Endocrine
2.Neurological
3.Mucocutaneous
4.Hematological
Syndrome class Syndrome
Main causal
cancers
Causal mechanism
Endocrine
Hyperaldosteronism
•Adrenal
adenoma / Conn's
syndrome
•Non-Hodgkin's
lymphoma
•ovarian
carcinoma
Aldosterone
Cushing syndrome
•small-cell lung
cancer
•Pancreatic
carcinoma
•Thymoma
Ectopic ACTH and
ACTH-like
substance
SIADH
•Small-cell lung
cancer
Antidiuretic
hormone
Adrenal Adenoma/CONN’S syndrome
Non-Hodgkin’s
Lymphoma
on soft palate
Patients affecting with
Non-Hodgkin’s
Lymphoma
Syndrome class Syndrome
Main causal
cancers
Causal mechanism
Endocrine
Hyperaldosteronism
•Adrenal
adenoma / Conn's
syndrome
•Non-Hodgkin's
lymphoma
•ovarian
carcinoma
Aldosterone
Cushing syndrome
•small-cell lung
cancer
•Pancreatic
carcinoma
•Thymoma
Ectopic ACTH and
ACTH-like
substance
SIADH
•Small-cell lung
cancer
Antidiuretic
hormone
An
encapsulated
thymoma
(mixed
lymphocytic
and epithelial
type.)
SIAD
H
Syndrome
class
Syndrome
Main causal
cancers
Causal
mechanism
Endocrine
Carcinoid syndrome
•Bronchial
adenoma
(carcinoid type)
•Pancreatic
carcinoma
•Gastric
carcinoma
Serotonin,
Bradykinin
Hypoglycemia
•Fibrosarcoma
•Insulinoma
•Hepatocellular
carcinoma
Insulin or insulin-
like
substance or "big
" IGF-II
Symptoms of
Hypoglycemia
Syndrome
class
Syndrome Main causal cancers
Causal
mechanism
Paraneoplastic
cerebellar
degeneration
• Lung
• Ovarian cancer
• Breast carcinoma
• Hodgkin's
lymphoma
Neurological
Lambert-Eaton
myasthenic
syndrome (LEMS)
Small-cell lung
cancer
Immunologic
Polymyositis
•Non-Hodgkin
lymphoma
•lung cancers
•bladder cancers
Syndrome class Syndrome
Main causal
cancers
Causal mechanism
Mucocutaneous
Acanthosis
nigricans
•Gastric carcinoma
•Lung carcinoma
•Uterine carcinoma
•Immunologic
•Secretion of EGF
Dermatomyositis
•Bronchogenic
carcinoma
•Breast carcinoma
•ovarian cancer
•pancreatic cancer
•stomach cancer
Immunologic
Acanthosis
Nigricans Dermatomyositis
Syndrome
class
Syndrome
Main causal
cancers
Causal mechanism
Polycythemia
•Renal
carcinoma
•Hepatocellula
r carcinoma
Erythropoietin
Hematological Trousseau sign
•Pancreatic
carcinoma
•Bronchogenic
carcinoma
Mucins that
activate clotting
Anemia
•Thymic
neoplasms
Unknown
Thymic NeoplasmTrousseau
Sign
References
• Paraneoplastic Syndromes, 2011, Darnell & Posner
• NINDS Paraneoplastic Syndromes Information Page National
Institute of Neurological Disorders and Stroke
• Darnell,R.B., DeAngelis,L.M. (1993), "Regression of small-cell
lung carcinoma in patients with paraneoplastic neuronal
antibodies", Lancet 341 (8836): 21–22,
• Roberts,W.K., Darnell,R.B. (2004), "Neuroimmunology of the
paraneoplastic neurological degenerations"
• Albert,M.A., Darnell,R.B. (2004), "Paraneoplastic
neurological degenerations: keys to tumour
immunity", Nature Reviews Cancer 4 (1): 36–
44, PMID 14708025
• Paraneoplastic endocrine syndromes at the US National
Library of Medicine Medical Subject Headings (MeSH)
Paraneoplastic syndrome
Paraneoplastic syndrome

Paraneoplastic syndrome

  • 1.
  • 2.
    • A paraneoplasticsyndrome is a disease or symptom that is the consequence of cancer in the body but, not due to the local presence of cancer cells. • These phenomena are mediated by humoral factors (by hormones or cytokines) excreted by tumor cells or by an immune response against the tumor.
  • 3.
    • They appearin 10% to 15% of patients with cancer. • Paraneoplastic syndromes are typical among middle aged to older patients, and they most commonly present with cancers of the lung, breast, ovaries or lymphatic system (a lymphoma).
  • 4.
    • Paraneoplastic syndromes canbe divided into four main categories: 1.Endocrine 2.Neurological 3.Mucocutaneous 4.Hematological
  • 5.
    Syndrome class Syndrome Maincausal cancers Causal mechanism Endocrine Hyperaldosteronism •Adrenal adenoma / Conn's syndrome •Non-Hodgkin's lymphoma •ovarian carcinoma Aldosterone Cushing syndrome •small-cell lung cancer •Pancreatic carcinoma •Thymoma Ectopic ACTH and ACTH-like substance SIADH •Small-cell lung cancer Antidiuretic hormone
  • 6.
  • 7.
    Non-Hodgkin’s Lymphoma on soft palate Patientsaffecting with Non-Hodgkin’s Lymphoma
  • 10.
    Syndrome class Syndrome Maincausal cancers Causal mechanism Endocrine Hyperaldosteronism •Adrenal adenoma / Conn's syndrome •Non-Hodgkin's lymphoma •ovarian carcinoma Aldosterone Cushing syndrome •small-cell lung cancer •Pancreatic carcinoma •Thymoma Ectopic ACTH and ACTH-like substance SIADH •Small-cell lung cancer Antidiuretic hormone
  • 13.
  • 14.
    Syndrome class Syndrome Main causal cancers Causal mechanism Endocrine Carcinoid syndrome •Bronchial adenoma (carcinoidtype) •Pancreatic carcinoma •Gastric carcinoma Serotonin, Bradykinin Hypoglycemia •Fibrosarcoma •Insulinoma •Hepatocellular carcinoma Insulin or insulin- like substance or "big " IGF-II
  • 17.
  • 18.
    Syndrome class Syndrome Main causalcancers Causal mechanism Paraneoplastic cerebellar degeneration • Lung • Ovarian cancer • Breast carcinoma • Hodgkin's lymphoma Neurological Lambert-Eaton myasthenic syndrome (LEMS) Small-cell lung cancer Immunologic Polymyositis •Non-Hodgkin lymphoma •lung cancers •bladder cancers
  • 22.
    Syndrome class Syndrome Maincausal cancers Causal mechanism Mucocutaneous Acanthosis nigricans •Gastric carcinoma •Lung carcinoma •Uterine carcinoma •Immunologic •Secretion of EGF Dermatomyositis •Bronchogenic carcinoma •Breast carcinoma •ovarian cancer •pancreatic cancer •stomach cancer Immunologic
  • 23.
  • 24.
    Syndrome class Syndrome Main causal cancers Causal mechanism Polycythemia •Renal carcinoma •Hepatocellula rcarcinoma Erythropoietin Hematological Trousseau sign •Pancreatic carcinoma •Bronchogenic carcinoma Mucins that activate clotting Anemia •Thymic neoplasms Unknown
  • 25.
  • 26.
    References • Paraneoplastic Syndromes,2011, Darnell & Posner • NINDS Paraneoplastic Syndromes Information Page National Institute of Neurological Disorders and Stroke • Darnell,R.B., DeAngelis,L.M. (1993), "Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies", Lancet 341 (8836): 21–22, • Roberts,W.K., Darnell,R.B. (2004), "Neuroimmunology of the paraneoplastic neurological degenerations" • Albert,M.A., Darnell,R.B. (2004), "Paraneoplastic neurological degenerations: keys to tumour immunity", Nature Reviews Cancer 4 (1): 36– 44, PMID 14708025 • Paraneoplastic endocrine syndromes at the US National Library of Medicine Medical Subject Headings (MeSH)